Comparison of the Effect of Vaginal misoprostol with Oxytocin for the management pregnancy terminations with IUFD

Comparison of the Effect of Vaginal misoprostol with Oxytocin for the management of second trimester pregnancy terminations with IUFD in khalij fars hospital in Bandar Abbas in 2018.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181218042033N2

Enrollment

106

Registered

2020-02-24

Start date

2019-03-18

Completion date

Unknown

Last updated

2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrauterine fetal death. Complications following (induced) termination of pregnancy

Interventions

Intervention 1: Intervention group: Vaginal misoprostol: 400 µg every 6 hours up to 48 hours. Intervention 2: Control group: Oxytocin at a dose of 50 units of oxytocin at 500 cc Ringer (up to a maximu

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Pregnant women with 18 to 40 years of age confirmed by IUFD gestational age of 15 to 26 weeks

Exclusion criteria

Exclusion criteria: Multiparty more than 6 Coagulopathy Multi fetal pregnancy Any obstacle to induction of labor (e.g. maternal heart disease, clinical chorioamnionitis, vasa previa, placenta previa, invasive cervical carcinoma, myoma surgery or any surgery that has cut the uterine) Having one or more caesarean section History of any uterine incision (myomectomy and etc.).

Design outcomes

Primary

Measure	Time frame
Induction- to-delivery interval time. Timepoint: 6-48 hours after misoprostol and oxytocin administration. Method of measurement: clock.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAtena Gisooee

Bandare-abbas University of Medical Sciences

gisooeeatena@yahoo.com+98 76 3647 9830

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026